Advertisements


NewLink Genetics: Explicating The Changing Fundamentals Of A Potential Comeback

NewLink Genetics: Explicating The Changing Fundamentals Of A Potential Comeback.....»»

Category: topSource: seekingalphaMay 17th, 2018

The First Ebola Vaccine Has Been Approved in the US

NewLink Genetics and Merck shares made handy gains on Friday after it was announced that the FDA has granted approval to Ervebo, the Zaire Ebola virus vaccine V920......»»

Category: blogSource: 247wallstDec 20th, 2019

NewLink Genetics rejects unsolicited acquisition proposal from Evercel, Inc

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 16th, 2019

The Daily Biotech Pulse: Second Time"s The Charm For Sarepta, Pfizer"s Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer

The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Dec. 12.) 0 read more.....»»

Category: blogSource: benzingaDec 13th, 2019

NewLink Genetics advances over 11% after Evercel discloses rejected offer

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 12th, 2019

Evercel announces rejected offer to acquire NewLink Genetics

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 12th, 2019

NewLink Genetics announces EC conditional marketing approval for V920

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 12th, 2019

NewLink Genetics Corporation (NLNK) Management on Q3 2019 Results - Earnings Call Transcript

NewLink Genetics Corporation (NLNK) Management on Q3 2019 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaNov 8th, 2019

NewLink Genetics reports Q3 EPS (39c), one est. (27c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 6th, 2019

How Oregon Works: Teaching the fundamentals in changing sales industry

Consultant and sales veteran David Olsen teaches Portland State sales students to focus on research and communications......»»

Category: topSource: bizjournalsOct 11th, 2019

The Daily Biotech Pulse: Safety Scare For Anaptys" Psoriasis Drug, NewLink Genetics To Merge With Lumos, Insider Buy Props Up VBI Vaccines

The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 30.) read more.....»»

Category: blogSource: benzingaOct 1st, 2019

NewLink Genetics to host conference call

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 1st, 2019

NewLink Genetics trading resumes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 30th, 2019

NewLink Genetics trading halted, news pending

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 30th, 2019

Will This Ebola Vaccine Be the Next Big Thing?

NewLink Genetics shares jumped on Wednesday after the firm announced that the FDA has accepted Merck’s Biologics License Application and granted priority review for the investigational Ebola vaccine......»»

Category: blogSource: 247wallstSep 18th, 2019

NewLink Genetics Rallies After Ebola Vaccine Granted Priority Review Status

NewLink Genetics Corp (NASDAQ: NLNK) shares are poised to break above the $2 psychological barrier for the first time since early April after the company issued a regulatory update on a partne read more.....»»

Category: blogSource: benzingaSep 18th, 2019

The Daily Biotech Pulse: NewLink Genetics Rallies, Breakthrough Designation For Roche, IGM Biosciences Debuts

The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Sept. 17.) read more.....»»

Category: blogSource: benzingaSep 18th, 2019

NewLink Genetics says FDA accepts partnered BLA for ebola vaccine

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 17th, 2019

Bank Of America Downgrades EverQuote On Valuation Concerns

Although the fundamentals of EverQuote Inc’s (NASDAQ: EVER) underlying business and long-term growth potential remain positive, the strong rally in the stock calls for a downgrade, acc.....»»

Category: blogSource: benzingaSep 17th, 2019

Barron"s Picks And Pans: Apple, CSX, Tapestry, Total, Viacom And More

This weekend's Barron's offers a look at what's in store for North American railroad stocks. Other featured articles discuss changing oil stock dividends and potential results from a major media merger. read more.....»»

Category: blogSource: benzingaSep 14th, 2019

Canopy Growth Stock Is Short on Fundamentals, But High on Potential

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The markets have punished Canopy Growth stock for pinging red flags on fundamental me.....»»

Category: topSource: investorplaceAug 23rd, 2019